BXP three-lens brief
Evidence-based stock research on BXP. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Analyst mean target $69.40 — 19% above current (20 analysts). · Debt-to-equity of 212.0 — balance-sheet-heavy.
- Analyst mean target $69.40 — 19% above current (20 analysts).
- Debt-to-equity of 212.0 — balance-sheet-heavy.
BXP closed at $58.17 (-1.42%) as of 2026-05-13. Market cap: $10.37B. P/E (trailing) 29.2. Positives: analyst mean target $69.40 — 19% above current (20 analysts).. Concerns: debt-to-equity of 212.0 — balance-sheet-heavy.. Last quarter: Revenue $872.15M, net income $101.58M, free cash flow $941.12M.
Why three lenses on BXP, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BXPacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/BXP" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BXP brief"></iframe>